67 results on '"Newby, Kristin L"'
Search Results
2. 2015 ACC/AHA/SCAI focused update on primary percutaneous coronary intervention for patients with ST-elevation myocardial Infarction: An update of the 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention and the 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Society for Cardiovascular Angiography and Interventions
3. Do stable non–ST-segment elevation acute coronary syndromes require admission to coronary care units?
4. Association of standard clinical and laboratory variables with red blood cell distribution width
5. High-degree atrioventricular block, asystole, and electro-mechanical dissociation complicating non–ST-segment elevation myocardial infarction
6. BIOMARKERS: Troponin testing—risk stratification to stratified medicine
7. Myocardial Ischemia on Cardiac Stress Testing Does Not Cause Detectable Myocardial Necrosis: 822
8. Practice patterns and clinical outcomes among non-ST-segment elevation acute coronary syndrome (NSTE-ACS) patients presenting to primary and tertiary hospitals: Insights from the EARLY glycoprotein IIb/IIIa inhibition in NSTE-ACS (EARLY-ACS) trial
9. Responding to the letter to the editor by Saver
10. Association between bleeding and mortality among women and men with high-risk acute coronary syndromes: Insights from the Early versus Delayed, Provisional Eptifibatide in Acute Coronary Syndromes (EARLY ACS) trial
11. Diagnostic time course, treatment, and in-hospital outcomes for patients with ST-segment elevation myocardial infarction presenting with nondiagnostic initial electrocardiogram: A report from the American Heart Association Mission: Lifeline program
12. 2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities
13. Antithrombotic therapy for atrial fibrillation and coronary artery disease in older patients
14. REASONS FOR NONCOMPLETION OF ADVANCE DIRECTIVES IN A CARDIAC INTENSIVE CARE UNIT
15. Highlights from the IV International Symposium of Thrombosis and Anticoagulation (ISTA), October 20-21, 2011, Salvador, Bahia, Brazil
16. Baseline NT-proBNP and biomarkers of inflammation and necrosis in patients with ST-segment elevation myocardial infarction: insights from the APEX-AMI trial
17. Metabolic profiles predict adverse events after coronary artery bypass grafting
18. Left ventricular dysfunction screening in hypertensive patients with N-terminal pro-B-type natriuretic peptide and electrocardiogram
19. Highlights from the III International Symposium of Thrombosis and Anticoagulation (ISTA), October 14-16, 2010, São Paulo, Brazil
20. Troponin measurements during drug development—considerations for monitoring and management of potential cardiotoxicity
21. Atrial fibrillation, anticoagulation, fall risk, and outcomes in elderly patients
22. Association of metabolic syndrome and its individual components with outcomes among patients with high-risk non–ST-segment elevation acute coronary syndromes
23. Changes in glycoprotein IIb/IIIa inhibitor excess dosing with site-specific safety feedback in the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines (CRUSADE) initiative
24. Differences in Level of Care at the End of Life According to Race
25. Reporting and representation of race/ethnicity in published randomized trials
26. Characterization and outcomes of women and men with non-ST-segment elevation myocardial infarction and nonobstructive coronary artery disease: Results from the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the ACC/AHA Guidelines (CRUSADE) Quality Improvement Initiative
27. Risk factor management after acute coronary syndromes
28. Sex Differences in Mortality Following Acute Coronary Syndromes
29. Sex differences in medical care after acute myocardial infarction: what can be done to address the problem?
30. Early versus Delayed, Provisional Eptifibatide in Acute Coronary Syndromes
31. Incidence, distribution, and prognostic impact of occluded culprit arteries among patients with non-ST-elevation acute coronary syndromes undergoing diagnostic angiography
32. Clopidogrel use and bleeding after coronary artery bypass graft surgery
33. Unfractionated heparin dosing and risk of major bleeding in non-ST-segment elevation acute coronary syndromes
34. Transfusion practice and outcomes in non-ST-segment elevation acute coronary syndromes
35. Metabolic Efficiency with Ranolazine for Less Ischemia in Non-ST Elevation Acute Coronary Syndromes (MERLIN TIMI-36) study
36. Present and evolving role of eptifibatide in the treatment of acute coronary syndromes
37. Routine early eptifibatide versus delayed provisional use at percutaneous coronary intervention in high-risk non–ST-segment elevation acute coronary syndromes patients: An analysis from the Early Glycoprotein IIb/IIIa Inhibition in Non–ST-Segment Elevation Acute Coronary Syndrome trial
38. Embedding a randomized clinical trial into an ongoing registry infrastructure: Unique opportunities for efficiency in design of the Study of Access site For Enhancement of Percutaneous Coronary Intervention for Women (SAFE-PCI for Women)
39. Methodology of a reevaluation of cardiovascular outcomes in the RECORD trial: Study design and conduct
40. Results of a reevaluation of cardiovascular outcomes in the RECORD trial
41. Prevalence and clinical outcomes of undiagnosed diabetes mellitus and prediabetes among patients with high-risk non–ST-segment elevation acute coronary syndrome
42. Radial versus femoral access, bleeding and ischemic events in patients with non–ST-segment elevation acute coronary syndrome managed with an invasive strategy
43. TransRadial Education And Therapeutics (TREAT): Shifting the balance of safety and efficacy of antithrombotic agents in percutaneous coronary intervention: A report from the Cardiac Safety Research Consortium
44. Modifiable factors associated with failure to attain low-density lipoprotein cholesterol goal at 6 months after acute myocardial infarction
45. The Study Of LoSmapimod treatment on inflammation and InfarCtSizE (SOLSTICE): Design and rationale
46. Baseline metabolomic profiles predict cardiovascular events in patients at risk for coronary artery disease
47. Troponin T Levels in Patients with Acute Coronary Syndromes, with or without Renal Dysfunction
48. Safety and efficacy of adjusted-dose eptifibatide in patients with acute coronary syndromes and reduced renal function
49. Polymorphisms associated with in vitro aspirin resistance are not associated with clinical outcomes in patients with coronary artery disease who report regular aspirin use
50. Patterns of discharge antiplatelet therapy and late outcomes among 8,582 patients with bleeding during acute coronary syndrome: A pooled analysis from PURSUIT, PARAGON-A, PARAGON-B, and SYNERGY
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.